Til Schlotter
ETH Researcher, Co-founder & CEO
UNOMR AG
Zurich, Switzerland
Revolutionizing Precision Medicine with Nanopore-Based Protein Sequencing
My organisation
About me
Til Schlotter earned his BSc and MSc in Engineering from ETH Zurich and completed his diploma thesis at the University of British Columbia. He later completed his PhD at ETH Zurich, where he pioneered the development of the interface nanopore technology that powers UNOMR’s innovative approach to proteomics and precision medicine.
Before founding UNOMR AG, Til gained experience in strategy and business development as a management consultant at Deloitte and ETH Juniors.
As CEO, he leads application development, customer engagement, and fundraising to bring UNOMR’s platform to market. Under his leadership, the company has secured support from programs such as Venture Kick and InnoBooster, advancing its mission to make high-resolution protein modification analysis widely accessible across healthcare, pharmaceutical R&D, and food science.